| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.5000 | 
      | Human Intestinal Absorption | HIA+ | 0.9860 | 
      | Caco-2 Permeability | Caco2+ | 0.6931 | 
      | P-glycoprotein Substrate | Substrate | 0.6548 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.7442 | 
                                                     | Non-inhibitor | 0.7372 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9135 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7988 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8320 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8869 | 
      | CYP450 3A4 Substrate | Substrate | 0.6811 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9253 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8936 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9140 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8316 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8345 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8676 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9894 | 
                                                                    | Non-inhibitor | 0.8737 | 
      | AMES Toxicity | Non AMES toxic | 0.8689 | 
      | Carcinogens | Non-carcinogens | 0.8257 | 
      | Fish Toxicity | High FHMT | 0.8784 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9534 | 
      | Honey Bee Toxicity | High HBT | 0.7703 | 
      | Biodegradation | Not ready biodegradable | 0.9544 | 
      | Acute Oral Toxicity | III | 0.6658 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5877 |